RPRX icon

Royalty Pharma
RPRX

Overview Fund Activity

212 hedge funds and large institutions have $10.8B invested in Royalty Pharma in 2021 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 85 increasing their positions, 56 reducing their positions, and 34 closing their positions.

Holders
212
Holders Change
+14
Holders Change %
+7.07%
% of All Funds
3.73%
Holding in Top 10
11
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+10%
% of All Funds
0.19%
New
48
Increased
85
Reduced
56
Closed
34
Calls
$46.5M
Puts
$45.7M
Net Calls
+$871K
Net Calls Change
+$22.2M

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$2.1B
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$982M
3
BlackRock
3
BlackRock
New York
$596M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$1.22B
5
State Street
5
State Street
Massachusetts
$204M

Top Sellers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$1.08B
2
VCG
2
Vantage Consulting Group
Virginia
$380M
3
HMC
3
Harvard Management Company
Massachusetts
$467M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$54.1M
5
SCM
5
Suvretta Capital Management
New York
$41.7M
Name Market Value Shares Shares
Change 		Shares
Change %
Morgan Stanley
1
Morgan Stanley
New York
$2.1B 48,118,242 +24,320,161 +102%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$1.22B 27,952,820 +3,010,272 +12%
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$1.08B 24,687,756 -14,026,524 -36%
Vanguard Group
4
Vanguard Group
Pennsylvania
$982M 22,512,593 +20,673,627 +1,124%
Capital International Investors
5
Capital International Investors
California
$718M 16,449,101 -2,252 -0%
BlackRock
6
BlackRock
New York
$596M 13,664,581 +4,611,036 +51%
HMC
7
Harvard Management Company
Massachusetts
$467M 10,714,284 -3,976,496 -27%
VCG
8
Vantage Consulting Group
Virginia
$380M 8,705,551 -12,771,731 -59%
SGA
9
Siguler Guff Advisers
New York
$295M 6,761,970 – –
JPMorgan Chase & Co
10
JPMorgan Chase & Co
New York
$253M 5,795,267 -285,092 -5%
Wellington Management Group
11
Wellington Management Group
Massachusetts
$213M 4,893,133 -975,796 -17%
State Street
12
State Street
Massachusetts
$204M 4,685,863 +2,328,121 +99%
Victory Capital Management
13
Victory Capital Management
Texas
$139M 3,188,294 -519,438 -14%
AAMU
14
Amundi Asset Management US
Massachusetts
$121M 2,779,611 +831,887 +43%
Norges Bank
15
Norges Bank
Norway
$121M 2,763,137 +1,740,566 +170%
MSKCC
16
Memorial Sloan Kettering Cancer Center
New York
$117M 2,680,644 -885,243 -25%
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$103M 2,354,218 -854,937 -27%
Viking Global Investors
18
Viking Global Investors
Connecticut
$89.9M 2,061,753 -225,247 -10%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$84.1M 1,930,450 +677,943 +54%
GA
20
General Atlantic
New York
$65.4M 1,500,000 – –
Bank of America
21
Bank of America
North Carolina
$62.2M 1,425,879 +983,540 +222%
TCM
22
TimesSquare Capital Management
New York
$61.7M 1,415,615 -191,865 -12%
Legal & General Group
23
Legal & General Group
United Kingdom
$61.2M 1,402,572 +928,993 +196%
CCM
24
CAAS Capital Management
New York
$59.9M 1,372,123 -2,523,762 -65%
Northern Trust
25
Northern Trust
Illinois
$57M 1,305,633 +558,274 +75%
1
2 3 4 5